Si-Bone (SIBN) Liabilities and Shareholders Equity (2017 - 2026)
Si-Bone (SIBN) posted quarterly Liabilities and Shareholders Equity of $242.7 million for Q1 2026, up 6.79% year-over-year from $227.3 million in Q1 2025, and up 1.75% quarter-over-quarter from $238.6 million in Q4 2025.
Si-Bone (SIBN) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
Si-Bone's Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $242.7 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 6.79% year-over-year to $242.7 million; the TTM figure through Mar 2026 stood at $946.5 million (up 4.17% YoY), while the FY2025 annual figure was $238.6 million, up 3.52% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $242.7 million, up from $238.6 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $242.7 million in Q1 2026, with the low at $149.1 million in Q1 2023.
- The 5-year median for Liabilities and Shareholders Equity is $227.3 million (2025), against an average of $210.7 million.
- The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity declined 19.86% in 2022, then soared 50.07% in 2024.
- Si-Bone's Liabilities and Shareholders Equity stood at $157.6 million in 2022, then surged by 46.25% to $230.4 million in 2023, then rose by 0.01% to $230.4 million in 2024, then grew by 3.52% to $238.6 million in 2025, then increased by 1.75% to $242.7 million in 2026.
- Business Quant data shows SIBN's Liabilities and Shareholders Equity at $242.7 million in Q1 2026, $238.6 million in Q4 2025, and $234.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Si-Bone | 868.19 Mn | 722.25 Mn | 44.55 Mn | 248.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 248.76 Mn |
| Mar 31, 2026 | 242.72 Mn |
| Dec 31, 2025 | 238.56 Mn |
| Sep 30, 2025 | 234.27 Mn |
| Jun 30, 2025 | 230.92 Mn |
| Mar 31, 2025 | 227.28 Mn |
| Dec 31, 2024 | 230.44 Mn |
| Sep 30, 2024 | 227.00 Mn |
| Jun 30, 2024 | 223.84 Mn |
| Mar 31, 2024 | 223.71 Mn |
| Dec 31, 2023 | 230.43 Mn |
| Sep 30, 2023 | 230.88 Mn |
| Jun 30, 2023 | 233.83 Mn |
| Mar 31, 2023 | 149.08 Mn |
| Dec 31, 2022 | 157.55 Mn |
| Sep 30, 2022 | 158.27 Mn |
| Jun 30, 2022 | 166.15 Mn |
| Mar 31, 2022 | 176.85 Mn |
| Dec 31, 2021 | 190.51 Mn |
| Sep 30, 2021 | 193.97 Mn |